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Starvation elicits a complex adaptive response in anorganism.
No information on transcriptional regulation of metabolic
adaptations is available.We, therefore, studied the gene expres-
sion profiles of brain, small intestine, kidney, liver, and skeletal
muscle in mice that were subjected to 0–72 h of fasting. Func-
tional-category enrichment, text mining, and network analyses
were employed to scrutinize the overall adaptation, aiming to
identify responsive pathways, processes, and networks, and
their regulation. The observed transcriptomics response did not
follow the accepted “carbohydrate-lipid-protein” succession of
expenditure of energy substrates. Instead, these processes
were activated simultaneously in different organs during the
entire period. The most prominent changes occurred in lipid
and steroid metabolism, especially in the liver and kidney.
They were accompanied by suppression of the immune
response and cell turnover, particularly in the small intestine,
and by increased proteolysis in the muscle. The brain was
extremely well protected from the sequels of starvation. 60%
of the identified overconnected transcription factors were
organ-specific, 6% were common for 4 organs, with nuclear
receptors as protagonists, accounting for almost 40% of all
transcriptional regulators during fasting. The common tran-
scription factors were PPAR, HNF4, GCR, AR (androgen
receptor), SREBP1 and -2, FOXOs, EGR1, c-JUN, c-MYC,
SP1, YY1, and ETS1. Our data strongly suggest that the con-
trol of metabolism in four metabolically active organs is
exerted by transcription factors that are activated by nutrient
signals and serves, at least partly, to prevent irreversible brain
damage.
Adapting to starvation requires an interorgan integration of
the activity of metabolic pathways to protect the body from an
irreversible loss of resources (1, 2), but how the organism inte-
grates these reactions remains largely unknown. Numerous
studies on humans, who fasted for 3–6 weeks, have shown that
glycogen stores are depleted within a day (3). The decline in
circulating glucose and insulin during the next few days (4)
induces a transient increase in plasma (essential) amino acids
and a concomitant decline in plasma alanine levels due to an
increased hepatic extraction for gluconeogenesis (5, 6). Muscle
catabolism is amajor source of amino acids in this phase.When
fasting is continued, muscle protein catabolism declines, and
hepatic uptake of amino acids decreases, which is reflected in a
decline of endogenous glucose production (6) and urinary
nitrogen excretion (4, 7). Lipid catabolism and the (hepatic)
production of ketone bodies also increases rapidly and is quan-
titatively similar after 3 days and 5–6 weeks of starvation (8),
but plasma levels increase only gradually to plateau after 4
weeks (4, 9). The associated increase in urinary ketone body
(organic-acid) excretion requires a compensatory increase in
ammonia production and urinary excretion (4, 7, 10), which is
met by an increased renal amino acid uptake and gluconeogen-
esis (5, 6). As a result, the kidney and the liver produce similar
amounts of glucose (4, 6) and ammonia/urea (7) after 2–3
weeks of fasting. From the third week onward, the circulating
level of -hydroxybutyrate has become sufficiently high to
replace glucose as the fuel in e.g. the central nervous system
(11), but amino acids continue to be catabolized at a low rate
(12) because some tissues (erythrocytes) need glucose as fuel,
whereas the kidney needs to produce ammonia. This large body
of metabolomic data describes an essentially biphasic response
with an early phase in which proteins and fats are equally used
as energy sources and a late phase in which proteins are maxi-
mally conserved.
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Relatively few studies on prolonged fasting in mice are avail-
able, but in aggregate, the metabolomic data reveal both simi-
larities and differences with humans. We quantified a number
of metabolites in our previous fasting-related studies (13–16).
Plasma ammonia levels increased5-fold with the duration of
fasting in mice, whereas plasma -hydroxybutyrate increased
10-fold to a plateau of 1–2mMafter 24 h of fasting (14, 16, 17).
Plasma glucose and lactate concentrations declined tran-
siently at 36 and 48 h of fasting to return to prefasting levels
at 72 h of fasting (14). Supporting the validity of the increase
in plasma glucose levels was the initial depletion of glycogen
in the liver followed by a progressive reaccumulation in the
pericentral, that is, non-gluconeogenic part of the liver (14).
Similarly, many amino acids (alanine, serine, histidine, gly-
cine, arginine, citrulline, and phenylalanine) transiently
declined at 24 and 48 h of fasting to return to prefasting
levels at 72 h, whereas branched-chain amino acids, threo-
nine, asparagine, and taurine increased in concentration
with the duration of fasting. These data concur with human
data to the extent that increasing ammonia levels probably
reflect increasing renal production and excretion to com-
pensate for the increased organic acid (-hydroxybutyrate)
excretion. However, the transient decline in glucose, lactate,
and most amino acids clearly differs from the findings in
humans during prolonged fasting and still need further
research to be clarified. A subsequent study (15), which
focused on lipid metabolism, showed that the plasma con-
centration of cholesterol increased and that of triglycerides
decreased to new levels within 24 h, whereas fecal choles-
terol output declined progressively with the duration of fast-
ing. Hepatic triglyceride concentration increased after 24 h,
and hepatic and intestinal cholesterol and phospholipid con-
centrations increased after 48 h of fasting. Furthermore, we
observed an increase in biliary cholesterol, bile salt, and
phospholipid excretion, which we believe serves to nourish
enterocytes from the luminal side.
During the initial phase of fasting the rate of weight loss is
high but then declines to a minimum until the final, mori-
bund phase with more rapid weight loss sets in (18, 19).
Based on whole-body energy expenditure, these three phases
of weight loss were interpreted as reflecting successively the
postabsorptive utilization of glycogen reserves, oxidation of
fat (with a protein-sparing effect), and eventually the self-
destructive consumption of cell proteins (18, 20). However,
transcriptomics data from fasting muscle, small intestine,
and liver (13, 14, 21) suggest that increased protein degrada-
tion is an early response in muscle that is accompanied by a
temporary suppression of glutamine consumption in the
intestine and an up-regulation of gluconeogenic enzymes in
the liver. The late response of the intestine is primarily
directed to cell survival, whereas this phase is (unexpectedly)
characterized by a near-normalization of carbohydrate
metabolism in liver. Although data on long term starvation
in muscle, kidney, and brain are not available, these tran-
scriptomic data in rodents appear to concur with the human
metabolomic data that protein conservation during fasting
follows an initial phase during which protein catabolism is
liberally used to produce glucose and to contradict the
sequential model in which protein catabolism is a terminal
step in long term fasting.
This study aims to test the hypothesis that the adaptive
response of amouse to prolonged fasting involves an integrated
interorgan program of progressive metabolic adaptations that
subserves the maintenance of vital organ functions. The ques-
tion was addressed with a systems biology approach using tran-
scriptomics and advanced bioinformatics to analyze the adapt-
ive expression signatures of the small intestine, liver, kidney,
muscle, and brain. By analyzing the transcriptomes of five
organs at five different time points, we could produce a com-
prehensive view of the pathways, processes, and networks that
mediate this adaptive response. Our findings show that the
adaptive responses do not favor a succession of substrates used
for energy expenditure, but that pathways catabolizing carbo-
hydrates, fats, and proteins were activated simultaneously in
different organs. Themost prominent changes occurred in lipid
and steroid metabolism accompanied by suppression of the
immune response and cell turnover. Brain appeared to be well
protected against fasting. The result identified a set of tran-
scription factors that may mediate the spatiotemporal regula-
tion of general metabolism, cell turnover, and immune
response in response to fasting.
EXPERIMENTAL PROCEDURES
Animals and Organs—6-Week-old male FVB mice (Charles
River, Maastricht, The Netherlands) were fasted for 0, 12, 24,
48, or 72 h before sacrifice (n 8 per group; the 12-h groupwas
fasted overnight). 24 h before and during fasting, the animals
were kept in metabolic cages to prevent the consumption of
bedding and feces and were kept warm with an infrared lamp.
Body weight was determined daily. The daily rate of body- and
organ-mass loss was calculated in comparison to the previous
time point as described (22). Before organ harvesting
(between 9:00 and 10:00 a.m.), the animals were anesthetized
with 1.25 mg of ketamine and 2 g of dexmedetomidine per
10 g of body weight in 0, 12, and 24 h fasted and with a 20%
reduced amount in 48 and 72 h fasted mice. After blood
collection (lithium heparin) from the inferior caval vein,
mice were killed by decapitation. The organs (brain, kidney,
liver, small intestine, and calf muscle) were quickly isolated,
weighed, snap-frozen in liquid nitrogen, and stored at
80 °C. The entire procedure was carried out by five opera-
tors to expedite organ isolation and prevent RNA degrada-
tion. The animal studies were reviewed and approved by the
AMC committee for animal care and use.
RNA Isolation—Total RNA was extracted from the frozen
organs of eight animals per experimental group with TRIzol
reagent (Invitrogen) followed by a repeated phenol-chloroform
extraction, LiCl precipitation, and additional purification using
theRNeasyMini kit (QiagenBenelux,Venlo, TheNetherlands).
The RNA quality was assessed using the RNA 6000 Nano
LabChip kit in an Agilent 2100 bioanalyzer (Agilent Technol-
ogies, Palo Alto, CA). All samples had intact bands correspond-
ing to 18 S and 28 S ribosomal RNA subunits, displayed no
chromosomal peaks or RNA degradation products, and had an
RNA integrity number8. Five of eight animals per groupwere
chosen based on the best RNA quality across all five tissues, so
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that the RNAs used in this study all originated from the same
five mice per time point.
Microarrays—125 microarrays (5 time points, 5 mice per
time point, 5 tissues) were performed. We used a common-
reference design shown to be robust to low quality arrays, ame-
nable to clustering, and allowing for comparison of more than
two conditions at oncewithout dye effects (23). The single com-
mon-reference sample, a pool of equal amounts of RNA fromall
the samples investigated, was used in all arrays to allow for
quantitative comparisons across time points and tissues.
The microarray labeling and hybridization were performed
at the Microarray Department, University of Amsterdam.
Labeling and hybridization dayswere organized so that all com-
parisons could be analyzed with minimal confounding. One
experimental block containing all 25 samples per tissue was too
large to handle in a day. The blockswere, therefore, randomized
so that the same time points were not labeled/hybridized on the
same day. The Cy3-labeled test samples were hybridized
against the common-reference sample (Cy5-labeled) using
Microarray Department two-dye home-spotted arrays, printed
with the 22K65-mer Sigma/CompugenMouseOligoLibraryTM
with the oligo library reannotated as described (24).
Data Preprocessing, Clustering, and Statistical Analysis—All
analyses were carried out with packages from Bioconductor
(26) in the statistical software package R (Version 2.6.1). Esti-
mated foreground and background signals were extracted from
the ArrayVision files. Two arrays did not pass our quality con-
trol performed on the raw data due to spatial artifacts.
Background correction was performed using the “normexp”
method (27) to adjust the foreground signal without introduc-
ing negative values. The resulting log ratios were normalized
per array by print-tip loess. Because some of the control probes,
notably Gapdh, showed substantial between-tissue variation,
they were down-weighted to zero in the normalization step.
The statistical analysis of the data was performed within each
tissue separately by comparing 0 h versus all other time points.
Each probe except the controls was tested for any change in
expression over the 5 time points with a moderated F-test. Dif-
ferential expression for the pairwise comparisons between 0 h
and any of the other timepointswas assessed using amoderated
t test. Moderated tests are similar to the standard tests for each
probe, except that the standard deviations are moderated
across genes to ensure a more stable inference for each gene.
This prevents a gene from being judged as differentially
expressed with a very small -fold change merely because of an
accidentally small residual standard deviation (28). The result-
ing p values were corrected for multiple testing using the Ben-
jamini-Hochberg False Discovery Rate adjustment. Genes were
considered to be differentially expressed if the corrected p val-
ues were0.05 (while controlling the expected false discovery
rate to no more than 5%). Unsupervised hierarchical clustering
was performed both on the rawdata, as a quality control, and on
normalized data, with complete linkage and Pearson’s correla-
tion distance.
Functional Category Enrichment Analyses—Identification of
overrepresented functional categories (pathways and pro-
cesses) was performed per tissue using the complete set of dif-
ferentially expressed genes per time point (corrected p 0.05,
moderated t test) in the MetaCoreTM suit (Version 6.1;
GeneGo, Inc., St. Joseph,MI (29, 30)). The functional analysis of
the data were based on MetaCore’s proprietary manually
curated data base of protein-protein and protein-DNA interac-
tions, transcription factors, signaling, and metabolic pathways.
Overrepresented functional categories were identified as
described (31).
Network and Interactome Analyses—To study the regulation
of the responsive genes, we performed network analysis in
MetaCoreTM using two different algorithms, which both
deliver lists of subnetworks (one per transcription factor) but
begin from a different start point. The “transcriptional regula-
tion” algorithm starts with a small sub-network of differentially
expressed genes from the initial list and adds the “responsible”
transcription factors. The “transcription-factor target model-
ing” algorithm starts with list of transcription factors deduced
from the initial dataset and calculates the shortest paths to their
targets (31). The networks were generated for all five tissues
using unions of differentially expressed genes (corrected p 
0.05, moderated t test).
To identify the major transcriptional regulators in the data-
set, we used the statistical Interactome tool in MetaCoreTM. It
calculates relative connectivity (number of interactions) of
individual genes within the dataset compared with the entire
data base based on the comprehensive collection of their
known interactions (31). A genewas considered overconnected
if it hadmore direct interactions with the genes of interest than
it would be expected by chance (32). The related statistics are
described in detail elsewhere (31). Shortly, to assess signifi-
cantly over- or under-connected proteins in the list, Interac-
tome analysis evaluates relative connectivity of proteins based
on the assumption that themost critical protein in a given data-
set has more connections within the dataset than expected at
random. The interactions between proteins within a dataset
(local interactome) are compared with general connectivity
within the interactions data base (global interactome). Statisti-
cal significance is assigned by using the cumulative hypergeo-
metric distribution as
pk  
i  k
D
Pi,D,n,N, (Eq. 1)
where
Pk,D,n,N 
DkN  Dn  k
Nn
(Eq. 2)
N is the number of proteins (protein-based network objects) in
global interactome extracted from MetaCore, n is the number
of proteins derived from the sets of genes of interest, D is the
“degree” or number of interactions of a given protein in the
global interactome data base, and k is the degree of a given
protein within the set of interest. The p value calculated above
gives the probability of observing k or more interactions of a
given protein (with degreeD in the global network) by random
chance within the set of interest (of size n). The probability of
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observing under-connected proteins can be calculated by 1 
p(k). The resulting network of common and organ-specific reg-
ulators of fasting was created and visualized in Cytoscape (33)
and graphically enhanced in Adobe Illustrator CS2.
Text Mining—The CoPub text mining tool, which extracts
relationships between genes and keywords (e.g. pathways, dis-
eases, drugs, and Gene Ontology (GO) terms) from literature
(34, 35) was used to substantiate the transcriptomics findings.
CoPub calculates an R-scaled score between two co-occurring
concepts (i.e. genes and keywords) in Medline abstracts to
assign a degree of relatedness between the two concepts (rang-
ing from 0–100, representing non- to strong-association). It
takes into account the number of co-publications between two
concepts and the number of times each concept is separately
mentioned in literature (34–36). For each tissue, a keyword
enrichment analysis was performed to detect keywords signifi-
cantly associated with the set of differentially expressed genes
(raw p  0.01, moderated F-test). A keyword was regarded as
associated with a gene if it was co-mentioned in at least three
abstracts and had an R-scaled score of at least 35. Furthermore,
at least 10 regulated genes needed to be associated with a key-
word to include it in the keyword-enrichment analysis. Key-
wordswere regarded as enriched if p 0.01 in the Fisher’s exact
test. The CoPub web server is publicly available online.
A proof of principle validation of text mining analysis by
using publicly available datasets described and deposited at
GeneNetwork is described in supplemental File 1. The file also
contains a proof of principle validation of pathway analysis and
descriptions of all the supplemental files and figures.
RESULTS
Body and Organ Weight Loss upon Fasting—Provided they
are keptwarm,micewithstand 72 h of fastingwithout problems
and are still actively cruising their cage and hanging upside-
down from the top. Similar to our previous studies (13, 14), the
rate of bodyweight loss upon fastingwas highest during the first
12 h. During this period themice lost 12% of their initial weight
(Fig. 1), i.e. approximately a quarter when expressed on a per-
day basis (our common denominator for the 12- and 24-h-
fasted animals). From 12 to 24 h, the weight loss was only8%
per day and remained that low between 24 and 72 h so that the
animals had lost 30% of their initial weight after 3 days of
fasting. Confirming our previous findings, a preterminal
increase in the rate of body weight loss (as seen in e.g. rats (20))
was not observed. The liver, small intestine, and kidney fol-
lowed a similar trend, albeit that weight loss gradually became
more pronounced as fasting lasted longer. In total, these vis-
ceral organs lost 40–50% of their weight in 72 h. The decrease
in body weight and that of the three visceral organs was signif-
icant (p  0.001) at all the time points compared with that in
non-fastedmice. The weight loss of calf muscle was amoderate
10–15% per day on the first 2 days of fasting and became sig-
nificant on the third day only (p  0.004). In total, muscle
weight loss amounted to 30%. Of note, the brain was pro-
tected from weight loss even during prolonged fasting.
Global Changes in Organ Transcriptomes during 3 Days of
Fasting—The unsupervised hierarchical clustering of the raw
microarray data revealed that all but one microarray clustered
according to the organ fromwhich the RNAwas extracted (not
shown), demonstrating that biological variation exceeded tech-
nical variation and that the overall quality of the microarray
experiment was good. The non-fitting array (from liver, clus-
teringwith brain)was excluded from further analysis. Unsuper-
vised hierarchical clustering of the normalized microarray data
using 5237 genes differentially expressed in any of the tissues
(Fig. 2) confirmed clustering of arrays according to the organs
fromwhich they originated. It further revealed 10 distinct clus-
ters of genes, pointing both to the existence of concurrent mul-
tiorgan responses (e.g. clusters 1, 2, 3, and 9) and to tissue-
FIGURE 1. Rate of weight loss of body and organs during fasting. The rate of weight loss is calculated in comparison to the previous fasting time point and
expressed as percent change in weight per day. Whole-body weight loss and that of the three visceral organs was significant (p 103) at all the time points
compared with that in non-fasted mice. Muscle weight loss became significant only after 72 h (p 0.004), whereas no significant weight loss was seen in the
brain.
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specific responses to fasting (e.g. clusters 4, 6, 7, and 10). Gene
Ontology categories (37) statistically over-represented in these
clusters are summarized in Fig. 2 and shown in detail in supple-
mental File 2.
Todetermine the dynamics of the transcriptional response in
different tissues, each of the time points (12, 24, 48, and 72 h)
was compared with the fed condition (0 h) for each of the
organs studied. During the entire fasting period, (only) 45 genes
in the brain, 656 in the small intestine, 1252 in the kidney,
2068 in the liver, and 3057 in the muscle were differentially
expressed in a significant manner. Complete lists of differen-
tially expressed genes are shown in supplemental File 3. The
total number of differentially expressed genes (corrected p 
0.05) increased with the duration of fasting in each organ (Fig.
3A, left panel). The changes detected at each time point in com-
parison with the preceding time point (Fig. 3A, right panel)
revealed themagnitude of the response during the first 12 h and
the additive effect of the later periods. To introduce the direc-
tion of the changes in gene expression, we created heat maps of
differentially expressed genes for each of the organs (Fig. 3B),
with the significance threshold set to a corrected p 0.05. The
figure clearly demonstrates that the response in all organs
increased with the duration of fasting. Notably, the direction of
regulation of majority of the genes within an organ remained
unchanged (horizontal red or green lines).
Pathways and Processes Affected by Fasting in Functional-
categories Enrichment Analyses—To counteract an undue
influence of post-transcriptional regulation on our conclu-
sions, we have focused on pathways and networks rather
than on individual genes as the dependable read-out of
microarray analyses. We performed functional-categories
enrichment analyses in the MetaCoreTM suit to produce a
comprehensive overview of the canonical pathways and pro-
cesses altered by fasting. Table 1 shows the 10 most promi-
nently regulated pathways in four of the metabolically highly
active organs, with all the differentially expressed genes dur-
ing fasting taken into consideration (the complete lists of
regulated pathways are presented in supplemental File 4).
Cholesterol biosynthesis was the only significantly (down)
regulated canonical pathway in the brain (p  104),
whereas significant changes in 35, 54, 69, and 141 GeneGo
canonical pathways were found in intestine, kidney, liver,
and muscle, respectively. Clearly, the most prominent
changes in brain, liver, kidney, and intestine occurred in ste-
roid metabolism, in particular that of cholesterol, bile acids,
and steroid hormones. In kidney and liver, changes in
expression of lipid-metabolizing genes were very prominent,
whereas in intestine andmuscle and to a lesser extent kidney,
changes in expression of immune-response genes were nota-
ble. Cell-cycle regulating genes were highly affected in the
intestine, and cell-structure modulating genes were promi-
nently changed in muscle and intestine. Changes in the
expression of amino acid metabolizing genes were mostly
present in kidney, liver, and muscle. When these changed
canonical pathways were grouped, five metabolic processes,
as defined by MetaCoreTM (i.e. amino acid, carbohydrate,
lipid, steroid, and co-factor metabolism), emerged as the
main affected features. The outcome of enrichment analysis
for Gene Ontology categories was in excellent concordance
with these data (not shown).
FIGURE 2. Unsupervised hierarchical clustering of normalizedmicroarray data. Clustering of 122 microarrays that passed quality control was performed
using complete linkage andPearson correlation distance on the 5237genes thatwere differentially expressed in any of the tissues. The Z-score is calculated on
the rows by subtracting themean expression value of the row from each of the values and then dividing the resulting values by the standard deviation of the
row. Color in the heat maps, therefore, indicates the relative gene expression level, with red being higher and blue lower than the mean expression value.
Number of genes belonging to the 10 clusters is given on the corresponding branches of the dendrogram. Major Gene Ontology processes overrepresented
in those clusters are summarized on the right.
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To demonstrate the spatiotemporal coordination of dif-
ferent processes, we created a heat map with processes on
one axis and organs/time points on another axis depicting
the significance of the changes (Fig. 4A). The heat map dem-
onstrates clear dominance of lipid and steroid metabolism,
in particular in the liver and kidney. Vitamin and cofactor
metabolism comprises a number of pathways, e.g. vitamin E
and niacin-HDL metabolism, which only add weight to the
importance of lipid metabolism. The heat map further
reveals that the multiple processes were activated simulta-
neously in an organ and remained active during the entire
fasting period, stressing the interrelatedness of the response
across time and tissues. The current study detects the bipha-
sic response of carbohydrate metabolism in the intestine and
its attenuation in prolonged fasting in the liver (as seen in
our previous studies (13, 14)), but no obvious overall tempo-
ral trend in pathway regulation emerged.
To provide a substantiation of the outcome of the functional
category enrichment analysis, we tested one of the hypotheses
generated by this approach; that is, ketone body synthesis in the
fasted small intestine, a feature not previously linked to this
organ in adults. This biosynthetic process is usually associated
with the liver and kidney and was only observed in the small
intestine of newborn mice before weaning (38). We measured
the -hydroxybutyrate concentration in intestinal perfusates
from up to 48 h fasted mice from our previous study (15).
Although it was not present in detectable levels in the intestinal
lumen of fed animals, supplemental Fig. 1 demonstrates
FIGURE3.Numberofdifferentiallyexpressedgenesper timepointof fasting.PanelA, shown isnumberofgenes that aredifferentially expressed (corrected
p 0.05) in comparisonwith 0h fasting (left panel) and in comparisonwith the previous time point of fasting (12 versus 0, 24 versus 12 etc.; right panel). Fasting
generated a progressive adaptive response, but the most pronounced changes occurred during the first 12 h. Panel B, shown are heat maps containing all
differentially expressed genes in five organs at four fasting conditions. In each heat map a row represents a single gene, with red depicting significant
up-regulation, andgreendepicting significant down-regulation.Black indicates nodifferential expression at that timepoint. Geneswith similar behavior across
time (within an organ) are clustered together using complete linkage and Euclidean distance. The height of heat maps is scaled to (indirectly) reflect the
number of genes.
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increasing concentrations of this ketone body in the intestinal
lumen of mice with longer durations of fasting. This finding,
which is in good accordance with the increased excretion of
biliary lipids in the same study, corroborates the hypothesis that
the fasting small intestine acquires the capability to synthesize
ketone bodies (most likely using biliary phospholipids as
substrate).
Processes Differentially Regulated by Fasting as Revealed by
Text Mining Analyses—To substantiate the above findings
from a different perspective, CoPub keyword-enrichment anal-
ysis was performed using sets of differentially expressed genes
per tissue. In total, 7, 50, 94, 76, and 82 keywords were signifi-
cantly enriched in brain, intestine, kidney, liver, and muscle,
respectively (supplemental File 5). For an easier overview, we
grouped them into 28 higher order categories with amino acid,
fat, carbohydrate, energy, steroid and drug metabolism,
immune response, cell turnover, and protein metabolism con-
taining most of the enriched keywords. Results of the CoPub
analysis of these new (higher order) keywords are shown in
supplemental File 6. Fig. 4B presents a heat map depicting the
significance of keyword enrichment for these groupings for
each organ. Similarly to the fasting adaptations detected by the
analysis shown in Fig. 4A, fat and steroidmetabolismnoticeably
dominated the response. Carbohydrate metabolism, however,
came outmore prominently regulated than in theMetaCoreTM
analysis. Amino acid, energy, protein, and oxidative-stress
metabolism responded significantly to fasting in most organs.
Apart from the metabolic adaptations, cell turnover was signif-
icantly regulated in the small intestine and muscle. Keywords
linked to immune defense were enriched in the small intestine.
In the brain, as by now expected, very few higher order catego-
ries were found significantly represented (only cholesterol and
drug metabolism and neuronal signaling). Interestingly, based
on the gene expression profiles of these organs, the concept
“fasting” per se was enriched in kidney and liver.
We further performed a complementary, directed text min-
ing analysis to identify fasting-related genes in the set of all
differentially expressed genes. They were filtered from this set
based on the literature co-occurrence with the keywords “fast-
ing,” “caloric restriction,” “cachexia,” and “food deprivation”
TABLE 1
Tenmost prominently regulated canonical pathways in response to fasting
MIF, macrophage migration inhibitory factor; GPCR, G protein-coupled receptor; APC, adenomatosis polyposis coli; SCF, stem cell factor; WNT, Wnt (wingless-related
MMTV integration site) protein superfamily.
Pathway P value
Objects
Changed Out of
Intestine
Immune response; antigen presentation by MHC class I 8.06E-06 10 26
Cytoskeleton remodeling; regulation of actin cytoskeleton by Rho GTPases 1.55E-04 8 23
Immune response; CCR3 signaling in eosinophils 1.06E-03 12 59
Immune response; MIF, the neuroendocrine-macrophage connector 1.48E-03 8 31
Blood coagulation; GPCRs in platelet aggregation 1.69E-03 11 54
Cell cycle; role of APC in cell cycle regulation 1.85E-03 8 32
Cholesterol biosynthesis 3.36E-03 6 21
Cell cycle; the metaphase checkpoint 4.10E-03 8 36
Oxidative stress; role of ASK1 under oxidative stress 4.34E-03 6 22
Cell cycle; role of SCF complex in cell cycle regulation 4.40E-03 7 29
Kidney
Peroxisomal branched chain fatty acid oxidation 1.63E-06 12 22
Vitamin E (-tocopherol) metabolism 5.04E-06 10 17
Peroxisomal straight-chain fatty acid -oxidation 2.99E-05 7 10
Triacylglycerol metabolism 3.03E-04 11 29
Translation; regulation of translation initiation 3.46E-04 10 25
Cholesterol biosynthesis 3.73E-04 9 21
Mitochondrial long chain fatty acid -oxidation 5.95E-04 8 18
Bile acid biosynthesis 1.36E-03 10 29
Immune response; MIF, the neuroendocrine-macrophage connector 2.40E-03 10 31
Polyamine metabolism 2.81E-03 8 22
Liver
Cholesterol biosynthesis 5.53E-06 13 21
Peroxisomal branched chain fatty acid oxidation 1.14E-05 13 22
Lipoprotein metabolism I; chylomicron, VLDL and LDL 2.98E-05 7 8
Lipoprotein metabolism II; HDL metabolism 2.98E-05 7 8
Translation; regulation of translation initiation 7.16E-05 13 25
Androstenedione and testosterone biosynthesis and metabolism 7.24E-05 11 19
Triacylglycerol metabolism 1.08E-04 14 29
Estrone metabolism 1.11E-04 9 14
Vitamin E (-tocopherol) metabolism 1.31E-04 10 17
Aspartate and asparagine metabolism 2.42E-04 11 21
Muscle
Cytoskeleton remodeling 1.01E-06 42 96
Cytoskeleton remodeling; TGF, WNT, and cytoskeletal remodeling 1.11E-05 43 107
Immune response; antigen presentation by MHC class I 1.35E-05 16 26
Immune response; oncostatin M signaling via MAPK 1.72E-05 20 37
Neurodisease; Parkin disorder under Parkinson disease 1.80E-05 17 29
Proteolysis; role of Parkin in the ubiquitin-proteasomal pathway 1.09E-04 14 24
G-protein signaling; Ras family GTPases in kinase cascades 1.09E-04 14 24
Cell adhesion; chemokines and adhesion 1.44E-04 36 93
Transcription; Transcription regulation of amino acid metabolism 1.99E-04 14 25
Cytoskeleton remodeling; role of PKA in cytoskeleton reorganization 2.49E-04 16 31
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(for a complete list see supplemental File 7). Phosphoenolpyru-
vate carboxykinase 1 (Pck1)3 emerged as one of the most fre-
quently cited fasting-induced genes in liver and kidney. It was
also up-regulated in the small intestine together with glucose-
6-phosphatase (G6pc), indicating yet again (13, 39) the gluco-
neogenic potential of this organ after prolonged fasting. In
addition, the fasting-associated FoxO transcription factors, in
particular FoxO1 and FoxO3a, were up-regulated in kidney,
liver, and muscle. Pgc-1, a FoxO3a co-activator (40), was also
up-regulated in the long-fasted kidney andmuscle. In the small
intestine, the FoxO transcription factors were not regulated per
se, but some of their targets (Pck1 (41) andG6pc (42, 43)) were.
Furthermore, adiponectin receptors 1 and 2 (Adipor1 and -2),
which regulate glucose uptake and lipid catabolism (44, 45) and
were thus farmainly linked to obesity, also came prominent out
of this analysis. We now show them regulated in fasting in all
the studied tissues except kidney.
To demonstrate the validity of the text mining approach, we
analyzed the correlation of themRNAabundance of FoxO1 in the
livers of BxD genetic reference mouse population (obtained by
20-generation inbreeding in the F2 mice from an intercross
betweenC57BL/6J andDBA/2J strains (Ref. 46,GeneNetworkand
supplemental File 1) and its relationshipwith fasting glucose levels
(47). A remarkable negative correlation (r  0.90) was found
between FoxO1 expression and glucose concentration (supple-
mental Fig. 2). Interestingly, the second (among the top-scoring
500) gene-phenotype correlation for FoxO1was that with the lean
body mass (r  0.85 (47)). These relationships underline our
hypothesis thatFOXO1mayplay akey role in response tonutrient
deprivation and, by implication, to weight loss upon fasting.
Transcriptional Regulation of the Fasting Response by Net-
work and Interactome Analyses—To study the regulation and
biological connectivity of fasting-responsive genes in five dif-
ferent tissues, we performed network analyses for transcrip-
tional regulation and transcription factor-target modeling in
the MetaCoreTM suite. A list of networks (separate for each
transcription factor emerging from our fasting data) was built
for brain, intestine, kidney, liver, andmuscle using twodifferent
approaches (supplemental Files 8 and 9). The two different
algorithms (detailed under “Experimental Procedures”) gave
similar outcomes. Bymanually delineating themost prominent
hubs in a number of top scoring networks from both lists, we
obtained a list of transcription factors that was in surprisingly
close agreement with the overconnected genes obtained subse-
quently from the Interactome analysis.
To quantify the overconnectivity of the hubs as major fea-
tures of these networks and, thereby, the key regulators of fast-
ing response, we performed Interactome analysis using Meta-
Core. By evaluating changes in gene expression in the context of
a comprehensive data base of molecular interactions, this anal-
ysis identifies regulatory components of the biological net-
works that represent critical hubs driving the observed gene
expression changes that do not necessarily have to be changed
in expression themselves. The highly interconnected transcrip-
tion factors in each of the tissues in fasting are shown in sup-
plemental File 10. Almost 60% of the over-connected transcrip-
tion factorswere unique for an organ, ofwhich almost 90%were
specific for muscle. 40% of the transcription factors were com-
mon for at least 2, 20% for at least 3, and 6% for at least 4 organs.
The network that links the common and organ-specific regula-
tors with the corresponding organs is shown in Fig. 5. It
revealed SREBP1 as the only transcriptional regulator highly
interconnected in all five tissues in fasting. Furthermore, a set of
TFs (SREBP2, the nuclear-hormone receptors AR (androgen
receptor), GCR, PPAR, and HNF4, and C-JUN, SP1,
C-MYC, YY1, ETS1, and EGR1) appears to orchestrate the fast-
ing response in fourmetabolically highly active organs. In keep-
ingwith the fact thatmajor regulators of lipidmetabolism, such
as HNF4 and SREBP1, were the major hubs of several top
scoring networks in the liver, a whole set of network members
responsive to lipid levels, like Car, Pxr, Ppar, and Lrh, was
up-regulated in this organ. Similarly, a number of nuclear
receptors were up-regulated in muscle (e.g. Ror, Ror, Rar,
andCebp). Interestingly, in addition to FOXO1 and FOXO3A,
pointed out by ourCoPub textmining, the Interactome analysis
revealed four other members of forkhead gene family as major
regulators of fasting response (FOXM1 in the intestine, FOXK1
in muscle, and FOXD3 and FOXQ1 in the liver).
DISCUSSION
The adaptive response to fasting in major organs has been
studied extensively (65,000 hits in PubMed) but usually per
function and per organ. The absence of comprehensive studies
of the transcriptional adaptations to fasting is themore surpris-
ing in viewof the extensive studies on humans thatwere cited in
the Introduction and recently reviewed (3). Our study aimed to
deduce factors that regulate the metabolic integration between
the organs from gene expression profiles. They revealed that
carbohydrate, fat, and protein catabolism were activated con-
currently, although the features and intensities of their
response were specific for each of the studied organs. Themost
prominent changes in the four metabolically highly active
organs (especially liver and kidney) occurred in lipid and ste-
roid metabolism. They were accompanied by suppression of
the immune response and cell turnover in intestine andmuscle
and a generally enhanced defense against oxidative damage,
probably to cope with the highly increased fat oxidation. Brain,
however, was extremely well protected. Themicroarray studies in
rodents that have prospected the adaptive response to fasting of
the small intestine (13), liver (14, 48), and muscle (21, 49, 50) and
3 The abbreviations used are: Pck1, phosphoenolpyruvate carboxykinase 1;
AP-1, transcription factor AP-1 (protein superfamily); CAR, constitutive
androstane receptor (nuclear receptor subfamily 1, group I, member 3,
Nr1i3); Cdkn1a, cyclin-dependent kinase inhibitor 1A (p21); C-MYC,myelo-
cytomatosis oncogene; Dhcr7, 7-dehydrocholesterol reductase; FoxO,
forkhead box O; G6pc, glucose-6-phosphatase; Hmgcr, 3-hydroxy-3-meth-
yl-glutaryl-CoA reductase;Hnf4a, hepatic nuclear factor 4 (nuclear recep-
tor subfamily 2, group A, member 1; Nr2a1); Lrh, liver receptor homolog 1
(nuclear receptor subfamily 5, group A, member 2 Nr5a2); Pgc-1, peroxi-
some proliferative activated receptor, , coactivator 1; PPAR, peroxi-
some proliferator-activated receptor  (nuclear receptor subfamily 1,
group C, member 1; Nr1c1); Pxr, pregnane X receptor (nuclear receptor
subfamily 1, group I,member 2; Nr1i2); Rar, retinoic acid receptor; Ror,
RAR-related orphan receptor  (nuclear receptor subfamily 1, group F,
member 1; Nr1f1); Ror, RAR-related orphan receptor ; SP1, trans-acting
transcription factor 1; AR, androgen receptor; c-Jun, Jun oncogene; EGF,
epidermal growth factor; EGR, early growth response; GCR, glucocorticoid
receptor, Nr3c1; SREBP, sterol regulatory element binding transcription
factor.
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the currentmultiorgan study, therefore, reveal a scenario that dif-
fers from the “sugars-fats-proteins” succession of energy sub-
strates. For the whole body, this sequence of substrates was pro-
posed to characterize the postabsorptive, coping, and preterminal
phases of the adaptation to fasting, respectively (18, 51). Within
hours after the lastmeal, the organs respondwith changes in gene
expression. In this “early response,” adaptive changes in general
metabolism prevail that include carbohydrate, fat, and protein
metabolism, although the most prominent response occurred in
lipid and steroid metabolism. After 24 h of fasting, the temporary
early response is replacedbya response focusedona slow-downof
cell turnover and immune responses.
In agreement with a requirement for the preservation of glu-
cose for cell types that are exclusively dependent on it (most
importantly, brain and erythrocytes (52)), all forms of fatty acid
oxidation were impressively up-regulated under control of
Ppar (liver, kidney, intestines, and muscle) and Pgc1 (kidney
and muscle). This response was not restricted to muscle and
liver (53, 54); it started shortly after the beginning of the fast in
all four organs and persisted into the late response. Fatty acid
oxidation was accompanied by a strong increase in expression
of genes involved in ketone body synthesis in the small intes-
tine, kidney, and liver, a property thus far hardly ascribed to the
intestine (55, 56). At the same time, expensive cholesterol syn-
thesis was strictly controlled by down-regulation of the genes
encoding key synthetic enzymes (e.g. Hmgcr and Dhcr) in liver
and kidney (supplemental File 3). Up-regulation of the bile-acid
synthesis pathway in the kidney does not imply that this organ
FIGURE 4. Interorgan similarities anddifferences inmetabolic processes affectedby fasting. Panel A, shown is spatiotemporal distribution of significantly
regulated processes (as defined in the MetaCoreTM suit) after functional-category enrichment analysis. The heat map visualizes significantly regulated
processes (y axis) in each of the organs at different time points of fasting (x axis). Panel B, higher order keywords enriched by fasting as produced by CoPub
keyword-enrichment analysis are shown. The heat map shows the level of significance of 28 higher order categories keywords for each of the organs for the
wholedurationof fasting. Color intensity depicts the significanceof the changeexpressed as thenegative logarithmofp values obtained inboth analyses. TCA,
tricarboxylic acid cycle.
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produces bile acids but reflects an adaptation in sterol metabo-
lism in response to fasting. Hydroxylation of cholesterol at the
27 position by the mitochondrial sterol 27-hydroxylase (2-fold
up-regulated, supplemental File 3), for instance, may serve to
regulate the mitochondrial cholesterol content (57). The body
limits the loss of cholesterol by a dramatic decrease in fecal
cholesterol excretion, whereas biliary output increases to pro-
vide the essential luminal nourishment to the enterocytes and
keep them viable for when food becomes again available (15).
Down-regulation of genes involved in synthesis of ceramides
and complex (glyco)sphingolipids in kidney and muscle also
became apparent from ourGeneOntology enrichment analysis
(data not shown). Although this decline can be explained by the
lack of precursors (58), it nonetheless indicates a strict tran-
scriptional regulation of insulin signaling in fasting at the level
of membrane organization. Also in brain, despite its limited
transcriptomics response to fasting, genes involved in choles-
terol biosynthesis were down-regulated. Given the significance
of intrinsic cholesterol biosynthesis in brain (59, 60) and the
fact that changes in cholesterol homeostasis lead to a wide vari-
ety of central nervous system disorders (61), the change in the
cholesterol synthesis pathway may point to increased vulnera-
bility of neuronalmembranes (62), leading to brain damage that
eventually occurs as a consequence of starvation (63).
The text mining analyses drew our attention to Foxo1 and
Foxo3a transcription factors, which otherwise could have passed
unnoticed, whereas the Interactome analysis revealed four other
members of the forkhead gene family as additional regulators of
the fasting response. FOXO transcription factors regulate
responses to oxidative stress, differentiation, cell-cycle arrest, and
cell death (40, 64, 65). They also control gluconeogenesis (via reg-
ulation of Pck1 and G6pc) and muscle atrophy (in conjunction
with Fbxo32) (64–67). In addition, hypothalamic FOXO1 regu-
lates food intake and energy homeostasis (by inhibiting leptin-in-
ducedgene transcription (68, 69)). In supportof the roleofFOXOs
as cell fate controllers, cell proliferationandapoptosiswereheavily
regulated in the fasted small intestine and muscle. Interestingly,
Foxo3awasnot found regulated in the fastedbrain, but p21,which
is activated by it (70), was. Given the wide variety of their diverse
binding partners (71), especially PPARs, that are involved in nutri-
ent sensing and regulation ofmetabolism, it is tempting to suggest
a major role for the FOXO transcription factors in a coordinated
interorgan response to fasting.
Thenetwork and Interactomeanalyses highlighted anumberof
transcription factors as themajor regulatorofoverall adaptation to
fasting inmice. Theprominence ofmembers of the nuclear recep-
tor family is striking, accounting for almost a quarter of all com-
mon transcription factors. These factors are predominantly pres-
ent in kidney, liver, and muscle. HNF4 coordinated the liver
response to fasting. It triggers pleiotropic effects on lipid metabo-
lism, glucose homeostasis, and inflammation and is a central reg-
ulator in the network of nuclear receptors that integrates liver
intermediate metabolism (72). Kidney response to fasting was,
among others, orchestrated by EGF signaling, which regulates cell
turnover, cell adhesion, inflammation, and matrix remodeling
(73). EGF signaling via EGR is heavily influenced by changes in
membrane lipid composition (74), likely to occur in fasting condi-
tions, further highlighting the importance of strict control of cho-
FIGURE 5. Common and organ-specific transcriptional regulators of the fasting response.Overconnectivity of transcription factors (the nodes of the primary
networksofdifferentially regulatedgenes)was calculated for eachorganusingMetaCore Interactomeanalysis. The resultingnetworkof commonandorgan-specific
regulatorswas created andvisualized inCytoscape andenhanced inAdobe Illustrator. The tissues are representedwith colored circles. Transcription factors, grouped
according to the organs for which they are commonor specific, are depicted in corresponding rounded squares/half-moons, respectively.
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lesterol levels. Further supporting the findings linked to regulation
of lipidmetabolism, theoverconnectivityofSREBP1was identified
in all organs studied. This promiscuous transcriptional activator is
essential for lipid homeostasis (as it regulates fatty acid, phospho-
lipid, and to a lesser degree, cholesterol metabolism) but also reg-
ulates the non-lipid pathways andwas recently suggested to play a
crucial role in maintenance of membrane lipid homeostasis (75).
AR, a prominent hub in all themetabolically active fasting tissues,
plays a role in cellular proliferation, survival, lipidmetabolism, and
differentiation (76). GCR affects inflammatory responses, cellular
proliferation, and differentiation in target tissues (77). Along the
same line, one of the most prominent hubs in the small intestine
networks, AP-1 transcription factors, regulate transcription of
genes involved in cellular proliferation, differentiation, apoptosis,
and transformation (78, 79). In muscle, SP1, c-MYC, and AP-1
(both c-JUNandc-FOS)were themain regulators of adaptation to
fasting. SP1 regulates the expression of numerous genes impli-
cated in the control of cell growth, differentiation, apoptosis,
angiogenesis, and immune response (80) while efficiently trans-
ducing insulin signaling to the nucleus (81, 82). AP-1 and c-MYC
proto-oncogenes are also essential components of cell prolifera-
tive machinery (83). The transcription factors identified by this
study indicate an integrated response of lipidmetabolism and cell
turnover as the hallmark of overall adaptation to fasting.
Finally, using the systems biology approach, we were able to
demonstrate at the transcriptome level what has been a priori
intuitively acknowledged; that is, the extreme protection of the
brain from the effects of prolonged fasting. Not many genes
were differentially expressed, with most of the changes occur-
ring after prolonged fasting. The switch to ketone body utiliza-
tion ismost likely brought about by the increasing level of-hy-
droxybutyrate alone (84) without an accompanying increase in
enzymes or transporters.
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